High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation
Tài liệu tham khảo
Marriott, 2009, National estimates of dietary fructose intake increased from 1977 to 2004 in the United States, J Nutr, 139, 1228, 10.3945/jn.108.098277
Havel, 2005, Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism, Nutr Rev, 63, 133, 10.1111/j.1753-4887.2005.tb00132.x
Basciano, 2005, Fructose, insulin resistance, and metabolic dyslipidemia, Nutr Metab (Lond), 2, 1, 10.1186/1743-7075-2-5
Koo, 2008, Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver, Biochim Biophys Acta, 1782, 341, 10.1016/j.bbadis.2008.02.007
Bray, 2004, Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity, Am J Clin Nutr, 79, 537, 10.1093/ajcn/79.4.537
Hein, 2005, Highs and lows of high fructose corn syrup: a report from the center for food and nutrition policy and its Ceres workshop, Nutr Today, 40, 253
Strable, 2010, Genetic control of de novo lipogenesis: role in diet-induced obesity, Crit Rev Biochem Mol Biol, 45, 199, 10.3109/10409231003667500
Burhans, 2015, Hepatic oleate regulates adipose tissue lipogenesis and fatty acid oxidation, J Lipid Res, 56, 304, 10.1194/jlr.M054429
Basaranoglu, 2015, Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction, Hepatobiliary Surg Nutr, 4, 109
Fon Tacer, 2011, Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation, J Lipids, 2011, 1, 10.1155/2011/783976
Keller, 2000, Implications of peroxisome proliferator-activated receptors (PPARs) in development, cell life status and disease, Int J Dev Biol, 44, 429
Roglans, 2007, Impairment of hepatic Stat-3 activation and reduction of PPAR alpha activity in fructose-fed rats, Hepatology, 45, 778, 10.1002/hep.21499
Lazo, 2008, The epidemiology of nonalcoholic fatty liver disease: a global perspective, Semin Liver Dis, 28, 339, 10.1055/s-0028-1091978
Dekker, 2010, Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome, Am J Phys Endocrinol Metab, 299, E685, 10.1152/ajpendo.00283.2010
Vilà, 2011, Lipid AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose, J Nutr Biochem, 22, 741, 10.1016/j.jnutbio.2010.06.005
National Research Council, 1996, 8
Jurgens, 2005, Consuming fructose-sweetened beverages increases body adiposity in mice, Obes Res, 13, 1146, 10.1038/oby.2005.136
Walker, 2014, Fructose content in popular beverages made with and without high-fructose corn syrup, Nutrition, 30, 928, 10.1016/j.nut.2014.04.003
Bligh, 1959, A rapid method of total lipid extraction and purification, Can J Biochem Physiol, 37, 911, 10.1139/o59-099
Fritsche, 1990, Effect of dietary alpha-linolenic acid on growth, metastasis, fatty acid profile and prostaglandin production of two murine mammary adenocarcinomas, J Nutr, 189, 52
Brunt, 1999, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroentrol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x
Jacometo, 2014, Linoleic and α-linolenic acid consumption over three generations exert cumulative regulation of hepatic expression of genes related to lipid metabolism, Genes Nutr, 9, 405, 10.1007/s12263-014-0405-7
De Moura, 2009, Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols, Br J Nutr, 101, 1178, 10.1017/S0007114508066774
George, 2003, Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis, J Hepatol, 39, 756, 10.1016/S0168-8278(03)00376-3
Connor, 1996, Differential mobilization of fatty acids from adipose tissue, J Lipid Res, 37, 290, 10.1016/S0022-2275(20)37616-1
Xu, 2013, Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP, Semin Liver Dis, 33, 301, 10.1055/s-0033-1358523
Araya, 2004, Increase in long-chain polyunsaturated fatty acid n-6/n-3 in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease, Clin Sci (Lond), 106, 635, 10.1042/CS20030326
Shimomura, 1998, Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver, J Biol Chem, 273, 35299, 10.1074/jbc.273.52.35299
Fujita, 2011, Novel findings for the development of drug therapy for various liver diseases: liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis, J Pharmacol Sci, 115, 270, 10.1254/jphs.10R14FM
Chong, 2008, Parallel activation of de novo lipogenesis and stearoyl-CoA desaturate activity after 3 d of high-carbohydrate feeding, Am J Clin Nutr, 87, 817, 10.1093/ajcn/87.4.817
Mozaffarian, 2010, Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes, Am J Clin Nutr, 92, 1350, 10.3945/ajcn.110.003970
Fabbrini, 2010, Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications, Hepatology, 51, 679, 10.1002/hep.23280
Olofsson, 2000, Intracellular assembly of VLDL: two major steps in separate cell compartments, Trends Cardiovasc Med, 10, 338, 10.1016/S1050-1738(01)00071-8
Namikawa, 2004, Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis, J Hepatol, 40, 781, 10.1016/j.jhep.2004.01.028
Abdelmalek, 2010, Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1961, 10.1002/hep.23535
Yamaguchi, 2007, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, 45, 1366, 10.1002/hep.21655
Zhang, 2014, CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis, J Hepatol, 61, 1365, 10.1016/j.jhep.2014.07.006
Rendeiro, 2015, Fructose decreases physical and increases body fat without affecting hippocampal neurogenesis and learning relative to an isocaloric glucose diet, Sci Rep, 5, 9589, 10.1038/srep09589
Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004
Fabbrini, 2009, Intra-hepatic fat, not visceral fat, is linked with metabolic complications of obesity, Proc Natl Acad Sci U S A, 106, 15430, 10.1073/pnas.0904944106
Min, 2012, Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease, Cell Metab, 15, 665, 10.1016/j.cmet.2012.04.004
Postic, 2008, Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, J Clin Invest, 118, 829, 10.1172/JCI34275